10-Q Filing

EXACT SCIENCES CORP CIK: 1124140 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001558370-18-006112`
Period End Date	20180630
Filing Date	20180801
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	exas-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 62 Cash Flow Statement 78 Comprehensive Income 16

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, Authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, Authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$180.41M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$225.66M	USD	Point-in-time
Preferred stock, Issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, Issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$48.92M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$77.49M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$347.22M	USD	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$996.50M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$36.27M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$26.42M	USD	Point-in-time
Inventory, net	`InventoryNet`	$35.41M	USD	Point-in-time
Common stock, Authorized shares	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, Authorized shares	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Inventory, net	`InventoryNet`	$26.03M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$16.46M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.05M	USD	Point-in-time
Common stock, Issued shares	`CommonStockSharesIssued`	122.60M	shares	Point-in-time
Common stock, Issued shares	`CommonStockSharesIssued`	120.50M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.31B	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	120.50M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$487.22M	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	122.60M	shares	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$79.99M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$140.47M	USD	Point-in-time
Intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$24.20M	USD	Point-in-time
Intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$23.11M	USD	Point-in-time
Other long-term assets, net	`OtherAssetsNoncurrent`	$7.15M	USD	Point-in-time
Other long-term assets, net	`OtherAssetsNoncurrent`	$8.77M	USD	Point-in-time
Total assets	`Assets`	$598.56M	USD	Point-in-time
Total assets	`Assets`	$1.48B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$16.14M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.99M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$49.13M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$60.05M	USD	Point-in-time
Accrued interest	`AccruedInterest`	$4.15M	USD	Point-in-time
Debt, current portion	`LongTermDebtCurrent`	$182.00K	USD	Point-in-time
Debt, current portion	`LongTermDebtCurrent`	$4.59M	USD	Point-in-time
Other short-term liabilities	`OtherLiabilitiesCurrent`	$3.18M	USD	Point-in-time
Other short-term liabilities	`OtherLiabilitiesCurrent`	$2.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$82.96M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$68.12M	USD	Point-in-time
Convertible notes, net	`ConvertibleDebtNoncurrent`	$647.92M	USD	Point-in-time
Long-term debt, less current portion	`LongTermDebtNoncurrent`	$878.00K	USD	Point-in-time
Long-term debt, less current portion	`LongTermDebtNoncurrent`	$4.27M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.75M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$78.14M	USD	Point-in-time
Total liabilities	`Liabilities`	$738.26M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.01 par value Authorized5,000,000 shares issued and outstandingno shares at June 30, 2018 and December 31, 2017	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value Authorized5,000,000 shares issued and outstandingno shares at June 30, 2018 and December 31, 2017	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value Authorized200,000,000 shares issued and outstanding122,604,714 and 120,497,426 shares at June 30, 2018 and December 31, 2017	`CommonStockValue`	$1.21M	USD	Point-in-time
Common stock, $0.01 par value Authorized200,000,000 shares issued and outstanding122,604,714 and 120,497,426 shares at June 30, 2018 and December 31, 2017	`CommonStockValue`	$1.23M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.68B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.38B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-750.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-418.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-379.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.88M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-936.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-860.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$520.42M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$744.39M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$598.56M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.48B	USD	Point-in-time

Income Statement 62 line items

Line Item	Tag	Value	Unit	Period
Laboratory service revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$57.65M	USD	1 Quarter
Laboratory service revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$102.89M	USD	1 Quarter
Laboratory service revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$193.19M	USD	2 Qtrs
Laboratory service revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$106.01M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$34.97M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$17.99M	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$49.80M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$26.89M	USD	1 Quarter
Gross margin	`GrossProfit`	$71.04M	USD	2 Qtrs
Gross margin	`GrossProfit`	$143.39M	USD	2 Qtrs
Gross margin	`GrossProfit`	$76.01M	USD	1 Quarter
Gross margin	`GrossProfit`	$39.66M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$14.71M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$17.74M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$29.65M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$9.74M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$24.61M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$39.56M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$75.13M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$44.68M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$107.84M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$75.53M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$54.43M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$36.73M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$71.07M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$137.95M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$108.71M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$212.62M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-66.91M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-69.23M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-32.70M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-31.42M	USD	1 Quarter
Investment income	`InvestmentIncomeInterest`	$1.28M	USD	2 Qtrs
Investment income	`InvestmentIncomeInterest`	$683.00K	USD	1 Quarter
Investment income	`InvestmentIncomeInterest`	$8.59M	USD	2 Qtrs
Investment income	`InvestmentIncomeInterest`	$4.92M	USD	1 Quarter
Interest expense	`InterestIncomeExpenseNet`	$-104.00K	USD	2 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-8.60M	USD	1 Quarter
Interest expense	`InterestIncomeExpenseNet`	$-54.00K	USD	1 Quarter
Interest expense	`InterestIncomeExpenseNet`	$-15.11M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-6.52M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$629.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-3.69M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$1.17M	USD	2 Qtrs
Net loss before tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-65.74M	USD	2 Qtrs
Net loss before tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-30.79M	USD	1 Quarter
Net loss before tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-36.39M	USD	1 Quarter
Net loss before tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-75.75M	USD	2 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-1.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$58.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-30.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-36.39M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-65.74M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-75.81M	USD	2 Qtrs
Net loss per share-basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.30	USD	1 Quarter
Net loss per share-basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	1 Quarter
Net loss per share-basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.62	USD	2 Qtrs
Net loss per share-basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.59	USD	2 Qtrs
Weighted average common shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	112.85M	shares	1 Quarter
Weighted average common shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	111.72M	shares	2 Qtrs
Weighted average common shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	121.58M	shares	2 Qtrs
Weighted average common shares outstanding-basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	122.13M	shares	1 Quarter

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Issuance of shares of common stock to fund the Company's 401(k) matching contribution	`DeferredCompensationArrangementWithIndividualSharesIssued`	158.72M	shares	2 Qtrs
Issuance of shares of common stock to fund the Company's 401(k) matching contribution	`DeferredCompensationArrangementWithIndividualSharesIssued`	86.88M	shares	2 Qtrs
Net loss	`ProfitLoss`	$-75.81M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-65.74M	USD	2 Qtrs
Depreciation and amortization of property and equipment	`DepreciationAndAmortizationOfFixedAssets`	$8.81M	USD	2 Qtrs
Depreciation and amortization of property and equipment	`DepreciationAndAmortizationOfFixedAssets`	$6.76M	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-91.00K	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-96.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$12.22M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$28.06M	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$10.82M	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$920.00K	USD	2 Qtrs
Amortization of other liabilities	`AmortizationOfOtherLongTermLiabilities`	$769.00K	USD	2 Qtrs
Amortization of other liabilities	`AmortizationOfOtherLongTermLiabilities`	$1.14M	USD	2 Qtrs
Amortization of deferred financing costs	`OtherAmortizationOfDeferredCharges`	$26.00K	USD	2 Qtrs
Amortization of deferred financing costs	`OtherAmortizationOfDeferredCharges`	$49.00K	USD	2 Qtrs
Amortization of premium on short-term investments	`IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments`	$-1.39M	USD	2 Qtrs
Amortization of premium on short-term investments	`IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments`	$57.00K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$1.23M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$290.00K	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$4.15M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$9.85M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$14.06M	USD	2 Qtrs
Inventory, net	`IncreaseDecreaseInInventories`	$9.38M	USD	2 Qtrs
Inventory, net	`IncreaseDecreaseInInventories`	$5.58M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$6.41M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-242.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.14M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.53M	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-9.80M	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-268.00K	USD	2 Qtrs
Other short-term liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$69.00K	USD	2 Qtrs
Lease incentive obligation	`IncreaseDecreaseInLeaseIncentivePayable`	$683.00K	USD	2 Qtrs
Lease incentive obligation	`IncreaseDecreaseInLeaseIncentivePayable`	$-308.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-65.51M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-64.04M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$894.86M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$188.25M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$245.84M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$146.47M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.65M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$44.36M	USD	2 Qtrs
Purchases of intangible assets	`PaymentsToAcquireIntangibleAssets`	$8.44M	USD	2 Qtrs
Internally developed software	`PaymentsToDevelopSoftware`	$131.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-58.86M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-693.51M	USD	2 Qtrs
Proceeds from issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$896.42M	USD	2 Qtrs
Proceeds from exercise of common stock options	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$5.64M	USD	2 Qtrs
Proceeds from exercise of common stock options	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$772.00K	USD	2 Qtrs
Proceeds from sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$253.46M	USD	2 Qtrs
Proceeds in connection with the Company's employee stock purchase plan	`ProceedsFromStockPlans`	$2.66M	USD	2 Qtrs
Proceeds in connection with the Company's employee stock purchase plan	`ProceedsFromStockPlans`	$1.63M	USD	2 Qtrs
Payments of deferred financing costs	`PaymentsOfFinancingCosts`	$24.00K	USD	2 Qtrs
Proceeds from construction loan	`ProceedsFromIssuanceOfSecuredDebt`	$1.10M	USD	2 Qtrs
Payments on mortgage payable	`RepaymentsOfNotesPayable`	$86.00K	USD	2 Qtrs
Payments on mortgage payable	`RepaymentsOfNotesPayable`	$90.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$255.78M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$905.71M	USD	2 Qtrs
Effects of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$81.00K	USD	2 Qtrs
Effects of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$2.00K	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$131.49M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$148.17M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$180.41M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$225.66M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$48.92M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$77.49M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$180.41M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$225.66M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$48.92M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$77.49M	USD	Point-in-time
Property and equipment acquired but not paid	`NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1`	$2.10M	USD	2 Qtrs
Property and equipment acquired but not paid	`NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1`	$25.02M	USD	2 Qtrs
Unrealized loss on available-for-sale investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-1.13M	USD	2 Qtrs
Unrealized loss on available-for-sale investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-42.00K	USD	2 Qtrs
Issuance of 86,882 and 158,717 shares of common stock to fund the Companys 401(k) matching contribution for 2017 and 2016, respectively	`IssuanceOfStockToFundMatchingContributions`	$4.30M	USD	2 Qtrs
Issuance of 86,882 and 158,717 shares of common stock to fund the Companys 401(k) matching contribution for 2017 and 2016, respectively	`IssuanceOfStockToFundMatchingContributions`	$3.01M	USD	2 Qtrs
Interest paid	`InterestPaid`	$101.00K	USD	2 Qtrs
Interest paid	`InterestPaid`	$97.00K	USD	2 Qtrs

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-30.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-36.39M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-65.74M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-75.81M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-42.00K	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$476.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-37.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.13M	USD	2 Qtrs
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$2.00K	USD	2 Qtrs
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$89.00K	USD	1 Quarter
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$81.00K	USD	2 Qtrs
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-18.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-76.94M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-30.74M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-35.93M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-65.70M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.